Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTRACT: Infliximab in active Rheumatoid Arthritis
NCT00269867Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 1997
- Primary completion
- Mar 2000
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Mar 1997; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00269867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269867.